Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.60 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.44 |
| ▸ | LSS | P48449 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL7641027 | 0.93 | SLC22A1 (0.62) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL11853430 | 0.93 | SLC22A1 (0.62) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Sulfurous Acid SCHEMBL7645472 | 0.91 | SLC22A1 (0.48) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Sulfurous Acid SCHEMBL7637192 | 0.91 | SLC22A1 (0.48) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1073228 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL8589759 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3795428 | 0.87 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL5665834 | 0.87 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrapropylammonium SCHEMBL7637999 | 0.84 | SLC22A1 (0.56) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL11853414 | 0.82 | SLC22A1 (0.68) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842466-B1 | PRODUCT OF GLYCIDYL ETHER OF A MONO OR POLYHYDRIC PHENOL, EPOXY RESIN COMPOSITION, AND PROCESS FOR PRODUCING PRODUCT OF GLYCIDYL ETHER OF A MONO OR POLYHYDRIC PHENOL | CHANG CHUN PLASTICS CO LTD (TW) | 2025-10-01 | — | — | EP | claimed |
| US-20240425641-A1 | EPOXY RESINS | SPOLEK PRO CHEMICKOU A HUTNI VYROBU, AKCIOVA SPOLECNOST (CZ) | 2024-12-26 | — | — | US | claimed |
| US-20240409575-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. | 2024-12-12 | — | — | US | claimed |
| EP-4426768-A1 | EPOXY RESINS | Spolek Pro Chemickou A Hutni Vyrobu, Akciova Spolecnost (CZ) | 2024-09-11 | — | — | EP | claimed |
| EP-3362494-B1 | POLYURETHANE CATALYSTS FROM SULFUR BASED SALTS | EVONIK OPERATIONS GMBH (DE) | 2023-08-16 | — | — | EP | claimed |
| WO-2023078480-A1 | EPOXY RESINS | SYNPO, A.S. (CZ) | 2023-05-11 | — | — | WO | claimed |
| EP-4118085-A2 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. (US) | 2023-01-18 | — | — | EP | claimed |
| CN-115298181-A | Process for preparing 1' -cyanonucleosides | 吉利德科学公司 | 2022-11-04 | — | — | CN | claimed |
| US-20210309689-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. | 2021-10-07 | — | — | US | claimed |
| WO-2021183750-A2 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. (US) | 2021-09-16 | — | — | WO | claimed |
| EP-3207071-A1 | POLYURETHANE CATALYSTS FROM SULFUR BASED SALTS | Evonik Degussa GmbH (DE) | 2017-08-23 | — | — | EP | claimed |
| US-20160229945-A1 | POLYURETHANE CATALYSTS FROM SULFUR BASED SALTS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-08-11 | — | — | US | claimed |
| WO-2016061068-A1 | POLYURETHANE CATALYSTS FROM SULFUR BASED SALTS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-04-21 | — | — | WO | claimed |
| US-20160102169-A1 | Polyurethane Catalysts from Sulfur Based Salts | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-04-14 | — | — | US | claimed |
| CN-103412068-A | Determination method for OCPs in environmental sample | CSD IDEA BEIJING INST OF ENVIRONMENTAL INNOVATION CO LTD | 2013-11-27 | — | — | CN | claimed |
| EP-1006374-B1 | Process for producing a resin having a large refractive index | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-01-07 | — | — | EP | claimed |
| US-5843410-A | Polymeric ultraviolet screening agent and process for the preparation thereof | LG CHEMICAL LTD. (KR) | 1998-12-01 | — | — | US | claimed |
| US-4400397-A | Antithrombotic treatment with quaternary ammonium sulfites and bisulfites | T & R CHEMICALS, INC. (US) | 1983-08-23 | — | — | US | claimed |
| WO-1982000097-A1 | THE USE OF CERTAIN SULFITES OR BISULFITES IN COMPOSITIONS FOR TREATING THROMBOTIC CONDITIONS | T & R CHEM INC (US) | 1982-01-21 | — | — | WO | claimed |
| EP-0043274-A2 | Antithrombotic treatment | T AND R CHEMICALS, INC. (US) | 1982-01-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409575-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | PNP, TYMP, DUT | SLC22A1 1188/4885SLC22A2 1306/4885ALDH1A1 617/4885 |
| US-20210309689-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | PNP, TYMP, DUT | SLC22A1 1188/4885SLC22A2 1306/4885ALDH1A1 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.